Editorials

Standards of care in research

BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7475.1114 (Published 11 November 2004) Cite this as: BMJ 2004;329:1114
  1. Zulfiqar Bhutta, Husein Lalji Dewraj professor of paediatrics and child health (zulfiqar.bhutta@aku.edu)
  1. Aga Khan University, Karachi 74800, Pakistan

    Should reflect local conditions and not the best western standards

    The interpretation of “standard of care” in research has generated a lot of controversy among researchers. It has underpinned much of the debate on the use of placebos in randomised controlled trials such as the one around the zidovudine trials, which were proposed to prevent mother to child transmission of HIV infection in Africa. These trials entailed an evaluation of a short course treatment regimen in comparison with a control population receiving nothing.13 A high profile debate ensued that led to a reconsideration of guidelines on international research as well and spurred initiatives to make low cost antiretroviral treatment available in developing countries.4 5

    In October 2000, the World Medical Association modified the Helsinki declaration to state that “the benefits, risks, burdens and effectiveness of a new method should be tested against those of the best current prophylactic, diagnostic, and therapeutic methods.”6 The Council for …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe